Currently out of the existing stock ratings of Carey Macrury, 20 are a HOLD (27.78%), 52 are a BUY (72.22%).

Carey Macrury

Work Performance Price Targets & Ratings Chart

Analyst Carey Macrury, currently employed at CANACCORD, has had 68.75% of price targets met with an average potential upside of 35.6%, reached in 358 days on average.

Carey Macrury has documented 119 price targets and ratings displayed on 19 stocks. The coverage is on the Basic Materials sector.

Most recent stock forecast was given on FNV, Franco-Nevada at 19-May-2026.

Wall Street Analyst Carey Macrury

Analyst best performing recommendations are on GATO (GATOS SILVER).
The best stock recommendation documented was for GATO (GATOS SILVER) on 10/22/2024. The price target of $16.16 was fulfilled within 20 days with a profit of $3.8 (19.04%), with a performance score of 9.52.

Average potential price target upside

AEM Agnico Eagle Mines AUY Yamana Gold BTG B2Gold Corp EGO Eldorado Gold Corp FNV Franco-Nevada GOLD Barrick Gold Corp IAG IAMGold KGC Kinross Gold NEM Newmont Goldcorp Corp RGLD Royal Gold SA Seabridge Gold SAND Sandstorm Gold Ltd N WPM Wheaton Precious Metals Corp GSS Golden Star Resources Ltd MMX Maverix Metals NSR Nomad Royalty Company Ltd GATO Gatos Silver TFPM Triple Flag Precious Metals Corp GROY Gold Royalty Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 22-May-2026

$215

$36.55 (20.48%)

$218

14 days ago
(02-Nov-2026)

3/5 (60%)

$49.62 (30.00%)

56

Hold Since 18-Feb-2026

$190

$11.55 (6.47%)

$179

26 days ago
(21-Oct-2026)

5/5 (100%)

$2.64 (1.41%)

32

Hold Since 11-Apr-2025

$190

$11.55 (6.47%)

$170

1 months 8 days ago
(08-Oct-2026)

9/9 (100%)

$6.13 (3.33%)

28

Hold Since 09-Jul-2026

$225

$41.31 (22.49%)

$210

2 months ago
(16-Sep-2026)

9/10 (90%)

$29.43 (15.05%)

215

Buy Since 16-Feb-2021

$260

$81.55 (45.70%)

$276

4 months 2 days ago
(14-Jul-2026)

8/10 (80%)

$115.91 (80.44%)

130

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Carey Macrury?

On 2019
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?